1. Ahmad U, Hussain MT, Faiyazuddin M (2015a) Nanotechnology based chemopreventive approaches to improve the oral delivery of Silymarin in liver cancer. In: Bhoop BS, Sharma A, Mehta SK, Tripathi SK (eds) Nanotechnology: novel perspectives & prospects. Tata McGraw Hill Education, New York, pp 809–817. ISBN: 978-93-39221-09-6
2. Ahmad U, Faiyazuddin M, Hussain MT, Ahmad S, Alshammari TM, Shakeel F (2015b) Silymarin: an insight to its formulation and analytical prospects. Acta Physiol Plant 37(11):253
3. Alexiou C, Schmid RJ, Jurgons R, Kremer M, Wanner G, Bergemann C, Huenges E, Nawroth T, Arnold W, Parak FG (2006) Targeting cancer cells: magnetic nanoparticles as drug carriers. Eur Biophys J 35:446–450
4. Allen TM, Cullis PR (2004) Drug delivery systems: entering the mainstream. Science 303:1818–1822
5. Allen TM, Everest JM (1983) Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats. J Pharmacol Exp Ther 226:539–544